Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment

Study of the Functional State of the Proximal Renal Tubules in Patients with Asymptomatic Chronic Heart Failure in Dyslipidemia and its Correction with Simvastatin Treatment

Aim. To study indicators of epithelial dysfunction in the proximal renal tubules by determining the activity of organ-specific enzymes neutral α-glucosidase (NAG) and L-alanine aminopeptidase (LAAP), in patients with the initial stage of chronic heart failure in dyslipidemia, and the possibility of...

Full description

Bibliographic Details
Main Author:	V. Yu. Kopylov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2020-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	obesity dyslipidemia heart failure diabetes mellitus type 2 fermeture simvastatin
Online Access:	https://www.rpcardio.online/jour/article/view/2354

Similar Items

Assessment of Adding Fenofibrate to Simvastatin on Exercise Test Findings in Patients with Dyslipidemia and Coronary Artery Disease
by: Reza Karbasi Afshar, et al.
Published: (2013-12-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

The efficiency of dyslipidemia control in real clinical practice and the possibilities of its correction in patients with coronary heart disease and diabetes mellitus in the long -term use of simvastatin
by: F. Yu. Valikulova, et al.
Published: (2014-07-01)

Effects of simvastatin with or without fenofibrate on echocardiographic findings of patients with coronary artery disease and dyslipidemia: a brief report
by: Karbasi-Afshar R, et al.
Published: (2012-09-01)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
by: Tarantino N, et al.
Published: (2017-02-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)

PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2010-02-01)

Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure
by: Tetsuro Marunouchi, et al.
Published: (2023-01-01)

La fermeture précoce des stomies digestives: à propos de 66 cas colligés dans la clinique chirurgicale de l'Hôpital Aristide Le Dantec
by: Touré Fodé Baba, et al.
Published: (2016-04-01)

The Combination Effect of Simvastatin and Virgin Coconut Oil on Total Cholesterol Levels in Dislipidemic Male Albino Rats (Rattus norvegicus)
by: Lutfi Dewanda Nugroho, et al.
Published: (2021-08-01)

STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
by: I. N. Medvedev, et al.
Published: (2013-03-01)

Effect of Metformin and Simvastatin in Inhibiting Proadipogenic Transcription Factors
by: Jelena Jakab, et al.
Published: (2021-11-01)

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders
by: Agata Górniak, et al.
Published: (2023-02-01)

The efficacy and safety of Simvastatin in the treatment of lipid abnormalities in diabetes mellitus
by: Ogbera A Okeoghene, et al.
Published: (2013-01-01)

Soy milk versus simvastatin for preventing atherosclerosis and left ventricle remodeling in LDL receptor knockout mice
by: L. Santos, et al.

Severe rhabdomyolysis and acute renal failure secondary to use of simvastatin in undiagnosed hypothyroidism
by: Qari Faiza
Published: (2009-01-01)

Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin
by: Xuemei Liu, et al.
Published: (2020-06-01)

Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart
by: Ankur Rohilla, et al.
Published: (2012-01-01)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
by: Farnier Michel, et al.
Published: (2011-11-01)

Fermeture sociale, différence et diversité: des enjeux identitaires
by: Ionela Băluță
Published: (2011-11-01)

Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice
by: Zoe White, et al.
Published: (2022-11-01)

The influence of Simvastatin and Korargin on the clinical course of coronary heart disease, body weight and distribution of adipose tissue in patients with type 2 diabetes mellitus.
by: E. A. Pogrebniak
Published: (2013-06-01)

Evaluation of the relationship of immuno-inflammatory process with dyslipidemia and myocardial morphofunctional parameters in patients with chronic heart failure on the background of rheumatoid arthritis
by: A. S. Ankudinov, et al.
Published: (2020-09-01)

MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
by: I. N. Medvedev
Published: (2017-05-01)

Simvastatin retards cartilage degradation and subchondral bone deterioration induced by a high-fat diet in mice
by: Hetong Li, et al.
Published: (2023-12-01)

Hypolipidemic effect of methoxyflavone-enriched extract of Kaempferia parviflora in cholesterol-induced dyslipidemic rats
by: Somsuda Somintara, et al.
Published: (2019-04-01)

Bacteriostatic effect of simvastatin on selected oral streptococci in vitro
by: Eugene J Whitaker, et al.
Published: (2017-01-01)

Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
by: Ying Li, et al.
Published: (2019-04-01)

Simvastatin-induced Toxic Epidermal Necrolysis
by: Emmanouil Petrou, et al.
Published: (2014-01-01)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
by: Sunil K Kota, et al.
Published: (2013-01-01)

Chronic heart failure
by: J. A. Ker
Published: (2015-09-01)

Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
by: Khalid Al-Siyabi, et al.
Published: (2010-10-01)

Metabolite Signature of Simvastatin Treatment Involves Multiple Metabolic Pathways
by: Lilian Fernandes Silva, et al.
Published: (2022-08-01)

EFEK PEMBERIAN SIMVASTATIN TERHADAP KADAR KOLESTEROL TELUR PUYUH
by: Wiwik Febriani
Published: (2018-02-01)

Heart failure and obesity
by: Alfiya A. Safiullina, et al.
Published: (2022-10-01)

The Effect of Vitamin D Supplementation in Overweight or Obese Type 2 Diabetic Patients with Vitamin D Deficiency and Dyslipidemia
by: Sahar Shahriari, et al.
Published: (2018-12-01)

The Effect of Vitamin D Supplementation in Overweight or Obese Type 2 Diabetic Patients with Vitamin D Deficiency and Dyslipidemia
by: Sahar Shahriari, et al.
Published: (2018-12-01)

THE MECHANISMS OF HEART FAILURE DEVELOPMENT IN OBESITY
by: O. V. Gritsenko, et al.
Published: (2018-06-01)

Simvastatin treatment does not affect serum Vitamin D concentrations in patients with dyslipidemia: A randomized double-blind placebo-controlled cross-over trial
by: Mohsen Mazidi, et al.
Published: (2016-01-01)